DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Cholesterol impairs autophagy-mediated clearance of amyloid beta while promoting its secretion
Macroautophagy/autophagy failure with the accumulation of autophagosomes is an early
neuropathological feature of Alzheimer disease (AD) that directly affects amyloid beta (Ab) metabolism.
Although loss of presenilin 1 function has been reported to impair lysosomal function and prevent
autophagy flux, the detailed mechanism leading to autophagy dysfunction in AD remains to be
elucidated. The resemblance between pathological hallmarks of AD and Niemann-Pick Type C disease,
including endosome-lysosome abnormalities and impaired autophagy, suggests cholesterol accumulation
as a common link. Using a mouse model of AD (APP-PSEN1-SREBF2 mice), expressing chimeric mousehuman amyloid precursor protein with the familial Alzheimer Swedish mutation (APP695swe) and mutant
presenilin 1 (PSEN1-dE9), together with a dominant-positive, truncated and active form of SREBF2/SREBP2
(sterol regulatory element binding factor 2), we demonstrated that high brain cholesterol enhanced
autophagosome formation, but disrupted its fusion with endosomal-lysosomal vesicles. The combination
of these alterations resulted in impaired degradation of Ab and endogenous MAPT (microtubule
associated protein tau), and stimulated autophagy-dependent Ab secretion. Exacerbated Ab-induced
oxidative stress in APP-PSEN1-SREBF2 mice, due to cholesterol-mediated depletion of mitochondrial
glutathione/mGSH, is critical for autophagy induction. In agreement, in vivo mitochondrial GSH recovery
with GSH ethyl ester, inhibited autophagosome synthesis by preventing the oxidative inhibition of ATG4B
deconjugation activity exerted by Ab. Moreover, cholesterol-enrichment within the endosomes-lysosomes
modified the levels and membrane distribution of RAB7A and SNAP receptors (SNAREs), which affected its
fusogenic ability. Accordingly, in vivo treatment with 2-hydroxypropyl-b-cyclodextrin completely rescued
these alterations, making it a potential therapeutic tool for AD., This work was supported by Ministerio de Economía y Competitividad
under Grant: SAF2013-47246-R to A.C., SAF2015-66515-R to A.M., SAF2015-69944-R to J.F-C.); FEDER (Fondo Europeo de Desarrollo
Regional, Unión Europea. “Una manera de hacer Europa”); Fundació La
Marató de TV3 (2014-0930); Instituto de Salud Carlos III under Grant
PI13/00374 and PI16/00930 to M.M., US NIAAA under Center grant P50-
AA-11999 from Research Center for Liver and Pancreatic Diseases to J.F.
C. We also want to thank the support of the AGAUR (2014-SGR785) and
CERCA Programme from the Generalitat de Catalunya. C.dD. has a FPU
fellowship from Ministerio de Economía y Competitividad. This work was
developed (in part) at the Centre Esther Koplowitz., Peer reviewed
Proyecto:
MINECO / Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 SAF2013-47246-R
,
MINECO / Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 SAF2015-66515-R
,
MINECO / Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 SAF2015-69944-R